Related Experiment Video
Updated: Apr 7, 2026

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
Emerging pharmacological therapy for functional dyspepsia.
Mariko Hojo1, Akihito Nagahara2, Daisuke Asaoka2
1Gastroenterology, Juntendo University School of Medicine, Tokyo, Japan. mhojo@juntendo.ac.jp.
Functional dyspepsia (FD) treatment is complex. New drugs like acotiamide and herbal medicines show promise for improving symptoms and offering new therapeutic options.
Area of Science:
- Gastroenterology
- Pharmacology
- Herbal Medicine
Background:
- Functional dyspepsia (FD) is a common gastrointestinal disorder with multifactorial causes.
- Current treatment options for FD are limited and often ineffective.
- The pathophysiology of FD remains complex and not fully understood.
Purpose of the Study:
- To review recent advancements in pharmacological therapies for functional dyspepsia.
- To highlight novel drug candidates and herbal medicine approaches for FD management.
Main Methods:
- Literature review of recent pharmacological studies on functional dyspepsia.
- Analysis of clinical trial data for new FD treatments.
- Examination of research on herbal medicine efficacy in FD.
Main Results:
- Acotiamide, a new drug, demonstrates potential for improving postprandial distress syndrome symptoms.
- Herbal medicines are emerging as viable complementary or alternative treatment options for FD.
- Ongoing research is expanding the therapeutic landscape for FD.
Conclusions:
- Pharmacological advancements are offering new hope for functional dyspepsia patients.
- Acotiamide and herbal medicines represent promising avenues for FD treatment.
- Further research is needed to establish definitive treatments for FD.
Related Concept Videos
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...

